Recurrent meningioma: Salvage therapy with long-acting somatostatin analogue (vol 69, pg 969, 2007)

被引：0
|
作者：
Chamberlain
机构：
来源：
NEUROLOGY | 2008年 / 70卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：325 / 325
页数：1
相关论文
共 50 条
  • [21] The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly
    AlMaskari, M
    Gebbie, J
    KendallTaylor, P
    CLINICAL ENDOCRINOLOGY, 1996, 45 (04) : 415 - 421
  • [22] Effectiveness of slow-release lanreotide, a long-acting somatostatin analogue, in the treatment of acromegaly
    Chang, TC
    Chang, TJ
    Chen, MH
    Hsiao, YL
    Tsai, KS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (10) : 684 - 689
  • [23] Preparation of Long-Acting Somatostatin and GnRH Analogues and Their Applications in Tumor Therapy
    Yu, Fang
    Zhang, Tingting
    Fu, Fenghua
    Wang, Aiping
    Liu, Xinyong
    CURRENT DRUG DELIVERY, 2022, 19 (01) : 5 - 16
  • [24] INITIATION OF PATIENTS ONTO LONG-ACTING SOMATOSTATIN ANALOGUE THERAPY FOR NEUROENDOCRINE TUMORS: A SINGLE-CENTER REVIEW OF PRACTICE
    Tadman, Michael
    Charlton, Philip
    Jafar-Mohammadi, Bahram
    Talbot, Denis
    Grossman, Ashley B.
    ENDOCRINE PRACTICE, 2018, 24 (02) : 189 - 194
  • [25] Long-acting somatostatin analog therapy of acromegaly: A meta- analysis
    Freda, PU
    Katznelson, L
    van der Lely, AJ
    Reyes, CM
    Zhao, SH
    Rabinowitz, D
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (08): : 4465 - 4473
  • [26] Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995)
    Kapicioglu, S
    Gokce, E
    Kapicioglu, Z
    Ovali, E
    CEPHALALGIA, 1997, 17 (01) : 27 - 30
  • [27] Treatment of advanced pancreatic cancer with the long-acting somatostatin analogue lanreotide: in vitro and in vivo results
    M Raderer
    G Hamilton
    A Kurtaran
    J Valencak
    I Haberl
    O Hoffmann
    G V Kornek
    F Vorbeck
    M H L Hejna
    I Virgolini
    W Scheithauer
    British Journal of Cancer, 1999, 79 : 535 - 537
  • [28] Therapeutic innovations in endocrine diseases - Part 4: Pasireotide: Long-acting release somatostatin analogue
    Wemeau, Jean-Louis
    PRESSE MEDICALE, 2016, 45 (06): : E217 - E220
  • [29] Effects of the long-acting somatostatin analogue Lanreotide Autogel on glucose tolerance and insulin resistance in acromegaly
    Steffin, B.
    Gutt, B.
    Bidlingmaier, M.
    Dieterle, C.
    Oltmann, F.
    Schopohl, J.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2006, 155 (01) : 73 - 78
  • [30] Poly(alkyl cyanoacrylate) nanocapsules as a delivery system in the rat for octreotide, a long-acting somatostatin analogue
    Damge, C
    Vonderscher, J
    Marbach, P
    Pinget, M
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (10) : 949 - 954
12345